BRKR · NASDAQ
Bruker Corporation
$58.00 -0.18 (-0.31%)
Company overview
Bruker Corporation develops, manufactures, and distributes scientific instruments and analytical and diagnostic solutions in the United States and internationally. The company operates through three segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy and Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; the MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV-2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV-2 plus kits.
- Sector
- Healthcare
- Industry
- Medical - Devices
- Exchange
- NASDAQ
- Market cap
- $8.8B
- Employees
- 11,396
- Headquarters
- Billerica, MA
- Website
- bruker.com
- CEO
- Frank H. Laukien
- Listed
- August 4, 2000
- P/E
- -242.68
- Dividend yield
- 0.32%
Company financials
- Revenue
- $3.5B
- Gross profit
- $1.6B
- Operating income
- $204M
- EBITDA
- $317M
- Net income
- -$11.6M
- EPS
- -$0.24
- Total assets
- $6.1B
- Total debt
- $1.7B
- Gross margin
- 45.56%
- Net margin
- -0.34%
- Earnings yield
- -0.41%
Showing FY 2025
BRKR
1D
NASDAQ
O57.62H58.23L57.44C58.18+0.59 (+1.02%)Vol538.90K